11β-HSD1-IN-1

CAS No. 1203956-47-1

11β-HSD1-IN-1( —— )

Catalog No. M32755 CAS No. 1203956-47-1

11β-HSD1-IN-1 is an inhibitor of 11β-hydroxydehydrogenase 1 (11β-HSD1, IC50: 52 nM) used for the treatment of pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 115 In Stock
5MG 107 In Stock
10MG 158 In Stock
25MG 236 In Stock
50MG 324 In Stock
100MG 442 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    11β-HSD1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    11β-HSD1-IN-1 is an inhibitor of 11β-hydroxydehydrogenase 1 (11β-HSD1, IC50: 52 nM) used for the treatment of pain.
  • Description
    11β-HSD1-IN-1 is an inhibitor of 11β-hydroxydehydrogenase 1 (11β-HSD1), with an IC50 of 52 nM, and used for the treatment of pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Dehydrogenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1203956-47-1
  • Formula Weight
    399.77
  • Molecular Formula
    C18H14ClF4N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1C(=NN=C1C(OC2=C(F)C=C(F)C=C2F)(C)C)C3=C(Cl)C=C(F)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. THERAPEUTIC AGENT FOR PAIN. WO2012033070A1
molnova catalog
related products
  • LDH-IN-1

    LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.?LDH-IN-1 inhibits the growth of MiaPaCa2 pancreatic cancer and A673 sarcoma cells with IC50s of 2.23 and 1.21 μM).

  • Benzyl alcohol

    Benzyl alcohol is an aromatic alcohol; a colorless liquid with a mild pleasant aromatic odor.

  • CBR-5884

    CBR-5884 is an ?selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 μM.?CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity.?